160 related articles for article (PubMed ID: 16917835)
21. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
[TBL] [Abstract][Full Text] [Related]
22. Stereoselective binding of agonists to the β
Plazinska A; Plazinski W
Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
[TBL] [Abstract][Full Text] [Related]
23. Contribution of the extracellular cAMP-adenosine pathway to dual coupling of β2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscle.
Duarte T; Menezes-Rodrigues FS; Godinho RO
J Pharmacol Exp Ther; 2012 Jun; 341(3):820-8. PubMed ID: 22438472
[TBL] [Abstract][Full Text] [Related]
24. The β2-adrenoreceptor gene promoter polymorphisms may modulate β2-agonist- and glucocorticoid-induced IgE synthesis.
Chalubinski M; Grzegorczyk J; Grzelak A; Jarzebska M; Kowalski ML
Allergol Immunopathol (Madr); 2014; 42(6):586-93. PubMed ID: 24182991
[TBL] [Abstract][Full Text] [Related]
25. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.
Wnorowski A; Sadowska M; Paul RK; Singh NS; Boguszewska-Czubara A; Jimenez L; Abdelmohsen K; Toll L; Jozwiak K; Bernier M; Wainer IW
Cell Signal; 2015 May; 27(5):997-1007. PubMed ID: 25703025
[TBL] [Abstract][Full Text] [Related]
26. Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor.
Reinartz MT; Kälble S; Littmann T; Ozawa T; Dove S; Kaever V; Wainer IW; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):51-65. PubMed ID: 25342094
[TBL] [Abstract][Full Text] [Related]
27. β2-adrenoceptor agonist-evoked reactive oxygen species generation in mouse atria: implication in delayed inotropic effect.
Odnoshivkina UG; Sytchev VI; Nurullin LF; Giniatullin AR; Zefirov AL; Petrov AM
Eur J Pharmacol; 2015 Oct; 765():140-53. PubMed ID: 26297975
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.
Paul RK; Ramamoorthy A; Scheers J; Wersto RP; Toll L; Jimenez L; Bernier M; Wainer IW
J Pharmacol Exp Ther; 2012 Oct; 343(1):157-66. PubMed ID: 22776956
[TBL] [Abstract][Full Text] [Related]
29. Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonists.
Jozwiak K; Woo AY; Tanga MJ; Toll L; Jimenez L; Kozocas JA; Plazinska A; Xiao RP; Wainer IW
Bioorg Med Chem; 2010 Jan; 18(2):728-36. PubMed ID: 20036561
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([(18)F]FEFE) for the in vivo visualisation and quantification of the beta2-adrenergic receptor status in lung.
Schirrmacher E; Schirrmacher R; Thews O; Dillenburg W; Helisch A; Wessler I; Buhl R; Höhnemann S; Buchholz HG; Bartenstein P; Machulla HJ; Rösch F
Bioorg Med Chem Lett; 2003 Aug; 13(16):2687-92. PubMed ID: 12873495
[TBL] [Abstract][Full Text] [Related]
31. Stereoselective binding of chiral ligands to single nucleotide polymorphisms of the human organic cation transporter-1 determined using cellular membrane affinity chromatography.
Moaddel R; Bighi F; Yamaguchi R; Patel S; Ravichandran S; Wainer IW
Anal Biochem; 2010 Jun; 401(1):148-53. PubMed ID: 20206116
[TBL] [Abstract][Full Text] [Related]
32. Enhanced cardiac L-type calcium current response to beta2-adrenergic stimulation in heart failure.
Zhang ZS; Cheng HJ; Ukai T; Tachibana H; Cheng CP
J Pharmacol Exp Ther; 2001 Jul; 298(1):188-96. PubMed ID: 11408541
[TBL] [Abstract][Full Text] [Related]
33. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
[TBL] [Abstract][Full Text] [Related]
34. Revealing binding interaction between seven drugs and immobilized β2-adrenoceptor by high-performance affinity chromatography using frontal analysis.
Zhao XF; Huang JJ; Li Q; Wei LS; Zheng JB; Zheng XH; Li ZJ; Zhang YY
J Mol Recognit; 2013 May; 26(5):252-7. PubMed ID: 23526777
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
36. Altered beta2-adrenergic regulation of T cell activity after allergen challenge in asthma.
Heijink IH; van den Berge M; Vellenga E; de Monchy JG; Postma DS; Kauffman HF
Clin Exp Allergy; 2004 Sep; 34(9):1356-63. PubMed ID: 15347367
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2.
Gebauer L; Arul Murugan N; Jensen O; Brockmöller J; Rafehi M
Biochem Pharmacol; 2022 Mar; 197():114871. PubMed ID: 34902340
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, characterization, and metabolism studies of fluspidine enantiomers.
Holl K; Falck E; Köhler J; Schepmann D; Humpf HU; Brust P; Wünsch B
ChemMedChem; 2013 Dec; 8(12):2047-56. PubMed ID: 24130175
[TBL] [Abstract][Full Text] [Related]
39. Developmental changes in beta2-adrenergic receptor signaling in ventricular myocytes: the role of Gi proteins and caveolae microdomains.
Rybin VO; Pak E; Alcott S; Steinberg SF
Mol Pharmacol; 2003 Jun; 63(6):1338-48. PubMed ID: 12761344
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
Chae K; Gibson MK; Korach KS
Mol Pharmacol; 1991 Nov; 40(5):806-11. PubMed ID: 1944245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
